4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-價(jià)格

4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- 更多供應(yīng)商 1801344-14-8 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- 價(jià)格

更新日期	產(chǎn)品編號(hào)	產(chǎn)品信息	CAS號(hào)	包裝	價(jià)格	庫(kù)存信息	操作
2024/11/08	HY-135317	Emavusertib		1 mg	300元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	5 mg	600元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	10 mM * 1 mLin DMSO	660元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	10 mg	920元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	25 mg	1780元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	50 mg	2950元	In-stock	詳細(xì)
2024/11/08	HY-135317	4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- Emavusertib	1801344-14-8	100 mg	4700元	In-stock	詳細(xì)